ZYBERNO
Stock Report
Updated Aug 31, 2026

PEPGEN INC. (PEPG)

Healthcare • NASDAQ

$2.99

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
18.0/100
POOR BUSINESS
PEPGEN INC. (PEPG) scores 18/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-51.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.28x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-310.3%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

PEPGEN INC. (PEPG) stock report — Zyberno Score 18/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, PEPG generated -$77.27M in Owner Earnings. Capital was deployed as follows: $139.00K invested in capital expenditures. Reinvestment rate: 2.0%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:2.99
Market Cap:$206.92M

Valuation Multiples (2)

P/B Ratio:1.73x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$105.81M

Price Action & Momentum (1)

% of 52-Week High:38.3%
B. Profitability Assessment

Return Metrics (5)

ROA:-43.5%
Reinvestment Rate:2.0%
Fundamental Growth Rate (g):-6.2%

Margin Analysis (1)

Ebitda Margin:0.0%

Yield Metrics (2)

Earnings Yield:-$88.59
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-130.3%
Latest Earnings Filed:2026-08-06
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:13.36x
Quick Ratio:13.36x
Cash Ratio:13.01x

Leverage Analysis (3)

Debt To Equity Ttm:0.28x
Debt-to-Equity Ratio:0.28x
Debt To Ebitda:-999.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:111,324,000.00
Cash And Cash Equivalents:117,200,000.00
Long Term Debt:$12.86M
Net Debt:-$101.11M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$0.00
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$76.24M

Bottom Line Performance (3)

-$71.94M
Income Before Tax:-$71.86M
Ebitda Ttm:-74,940,000.00

Operating Expenses (5)

Operating Expenses:76,240,000.00
R And D Expense:52,800,000.00
Sga Expense:23,440,000.00
Income Tax Expense:$31.00K
Interest Expense:0.00

Expense Ratios (1)

Ebitda Margin:0.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$141.40M
Current Assets:$120.33M
Ppe Net:5,824,000.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:21,864,000.00
Current Liabilities:9,005,000.00
Long Term Debt:$12.86M
Short Term Debt:$3.23M

Equity & Capital (3)

Equity:$119.53M
Retained Earnings:-$396.69M
Common Stock:500,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:0.00
Accounts Payable:4,676,000.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:3,313,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$77.13M-$77.27M

Investment Activities (2)

Investing Cash Flow:-$1.46M
Capital Expenditures Ttm:139,000.00

Financing Activities (3)

Financing Cash Flow:$1.52M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:1,300,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-2.64
-$2.64
Earnings Per Share Ttm:-$1.04

Revenue & Cash Per Share (1)

Operating Cash Flow Per Share:-$1.18

Book Value & Capital (2)

Book Value Per Share:$1.73
Cash Per Share:1.69

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (1)

Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:-999.00
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:30.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$77.27M

Damodaran Growth Analysis (2)

Reinvestment Rate:2.0%
Fundamental Growth Rate (g):-6.2%
B. Log-Linear Regression Growth Analysis

Other Growth Rates (1)

Book Value Growth Rate (Linear):-11.6%
C. Company Profile & Context

Corporate Information (6)

Symbol:PEPG
Company Name:PEPGEN INC.
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:69.20M
Shares Outstanding Basic:69.20M
Shares Outstanding Diluted:69.20M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-31 18:40:35 UTC
Data Timestamp:2026-08-19T18:10:51.172979
Scroll to Top